Table 4b. Comparison at different thresholds between imaging and combined grades.
| Cutoff | κ | Sensitivity | CI | Specificity | CI | LR+ | CI | LR− | CI |
|---|---|---|---|---|---|---|---|---|---|
| Proliferative vs non-proliferative | 0.697 | 0.79 | 0.72–0.85 | 0.97 | 0.96–0.97 | 23.94 | 18.42–31.12 | 0.22 | 0.16–0.29 |
| Non-STDR vs sight-threatening DR | 0.540 | 0.81 | 0.78–0.83 | 0.75 | 0.72–0.77 | 3.17 | 2.86–3.52 | 0.26 | 0.22–0.30 |
| CSMO vs no CSMO | 0.624 | 0.72 | 0.67–0.77 | 0.94 | 0.93–0.95 | 11.95 | 9.83–14.54 | 0.29 | 0.24–0.36 |
| Any maculopathy vs no maculopathy | 0.512 | 0.70 | 66–0.73 | 0.82 | 0.80–0.84 | 3.95 | 3.49–4.47 | 0.37 | 0.33–0.41 |
Abbreviations: CI, confidence interval; LR+ and LR−, positive and negative likelihood ratios.
N=1963 for retinopathy; N=2110 for maculopathy with 27 missing data.